News & Events

What's happening with CU Innovations and our partners?

We collaborate and engage with the campus research community and innovation industry partners to advance scientific medical discovery. Watch for exciting news and press release articles posted here, along with updates on our annual events. Click "more stories" to see a complete listing of all of our news and follow us on LinkedIn and X for breaking CU Innovation news and events!  


Featured Innovation News

Economic Impact Report Image

CU Innovations: Pioneering Biomedical Technology & Boosting Economic Impact

Last year CU Innovations’ activities resulted in 145 invention disclosures, 189 patents filed, 41 licensing deals, $375MM of startup financing, and $35MM of gross revenue to the University of Colorado campus having a significant economic impact both in Colorado and nationwide.
View of a lake and mountains from canoe

Q32 Bio Announces Merger Closing with Homology Medicines & Private Placement of $42 Million

Q32 Bio Inc., a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, announced the completion of its merger with Homology Medicines, Inc. ("Homology").
Hands of a person typing on a laptop

Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy

Q32 Bio Inc. announced the publication of preclinical data in Molecular Therapy that further validates the therapeutic potential of ADX-097, a tissue-targeted complement inhibitor.

Annual Events

CU Innovations

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Suite 6202

Mail Stop F411

Aurora, CO 80045

303-724-6653

Twitter YouTube LinkedIn Vimeo
Healthcare Partners
CMS Login